A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
about
Evaluation of efficacy and safety for bevacizumab in treating malignant pleural effusions caused by lung cancer through intrapleural injection.A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity.15d-PGJ2 is a new hope for controlling tumor growth.Bevacizumab exacerbates sinusoidal obstruction syndrome (SOS) in the animal model and increases MMP 9 production.Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
P2860
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
@en
type
label
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
@en
prefLabel
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
@en
P2093
P2860
P921
P356
P1476
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
@en
P2093
Deok-Hoon Kong
Hee-Jun Na
Ji Hye Jang
Sukmook Lee
P2860
P356
10.3390/IJMS18081786
P407
P5008
P577
2017-08-17T00:00:00Z